Avadel Pharmaceuticals plc
Biotechnology ResearchView the employees at
Avadel Pharmaceuticals plc-
Rae Sanders (Lerner) Assistant Controller at Avadel Pharmaceuticals plc
-
Chesterfield, Missouri, United States
-
Rising Star
Colleen Eannarino *Specialty Sales Professional *Continuing Education Champion *Results-Oriented Coach *Training & Development Leader-
Greater Pittsburgh Region
-
Top 5%
Glynis Tavares Senior Director of Compliance at Avadel Pharmaceuticals plc-
Miami, Florida, United States
-
Top 5%
Brittney Kane Accounts Payable Specialist at Avadel Pharmaceuticals plc-
Greater St. Louis
-
Rising Star
Charles Mosseri Marlio Director of Strategic Planning and Investor Relations at Flamel Technologies-
France
-
Rising Star
Overview
Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Our current lead drug candidate, FT218, is an investigational formulation of sodium oxybate leveraging our proprietary drug delivery technology and designed to be taken once at bedtime for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. At Avadel, our core values foster an atmosphere of innovation and collaboration. In everything we do, we consider the patient experience, listening to their needs as we pursue the development and delivery of medicines that will transform the treatment landscape and have the greatest impact on people living with narcolepsy. Learn more about us at www.avadel.com and follow us on Twitter at @AvadelPharma.
-